Interview with Dr. Peter Traber, CEO of Galectin Therapeutics

Sully and Russ T Nailz interview Galectin Therapeutics CEO, Dr. Peter Traber. Dr. Traber discusses the very real progress that GALT is making with respect to liver diseases worldwide.

Galectin Therapeutics is a biotechnology company focused on discovery and development. GALT applies their leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer.

#GalectinTherapeutics #GALT #DrPeterTraber #LiverDisease #FattyLiver

Featured Posts
Recent Posts
Search By Tags
No tags yet.
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

© The BIG BIZ Show - All Rights Reserved

  • Facebook Social Icon
  • Twitter Social Icon
  • YouTube Social  Icon